ESSA Pharma Balance Sheet Health
Financial Health criteria checks 6/6
ESSA Pharma has a total shareholder equity of $128.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $132.7M and $3.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$130.69m |
| Equity | US$128.86m |
| Total liabilities | US$3.80m |
| Total assets | US$132.67m |
Recent financial health updates
Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth
Aug 21
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
Feb 18ESSA Pharma (NASDAQ:EPIX) Is In A Good Position To Deliver On Growth Plans
Aug 16We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Dec 15Recent updates
Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth
Aug 21We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
Feb 18ESSA Pharma (NASDAQ:EPIX) Is In A Good Position To Deliver On Growth Plans
Aug 16Estimating The Fair Value Of ESSA Pharma Inc. (NASDAQ:EPIX)
Jan 25We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Dec 15ESSA Pharma: Update Including Clinical Collaboration Agreement With Janssen
Feb 02ESSA Pharma and Janssen to test combo treatments in prostate cancer setting
Jan 13ESSA Pharma EPS beats by $0.02
Dec 15Financial Position Analysis
Short Term Liabilities: EPIX's short term assets ($132.1M) exceed its short term liabilities ($3.6M).
Long Term Liabilities: EPIX's short term assets ($132.1M) exceed its long term liabilities ($229.7K).
Debt to Equity History and Analysis
Debt Level: EPIX is debt free.
Reducing Debt: EPIX has no debt compared to 5 years ago when its debt to equity ratio was 709.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EPIX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: EPIX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 14.7% each year.